Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

48.440
-0.700-1.42%
Volume:7.71M
Turnover:381.01M
Market Cap:321.50B
PE:35.08
High:51.000
Open:49.740
Low:48.280
Close:49.140
52wk High:91.880
52wk Low:43.020
Shares:6.64B
HK Float Shares:258.00M
Volume Ratio:1.56
T/O Rate:2.99%
Dividend:0.23
Dividend Rate:0.48%
EPS(LYR):1.381
ROE:12.46%
ROA:7.02%
PB:4.26
PE(LYR):35.08
PS:8.77

Loading ...

HENGRUI PHARMA: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 9.87%

HK Disclosure
·
6 hours ago

HENGRUI PHARMA Has Repurchased 585,000 A Shares as of the End of September

Stock News
·
6 hours ago

HENGRUI PHARMA: The Capital Group Companies, Inc. Disposes of Shares, Long Position Falls to 10.96%

HK Disclosure
·
6 hours ago

Movement Alert|HENGRUI PHARMA Intraday Rise 3.68%, Buyback and Immunology Pipeline Optimism Drive Gains

Market Focus
·
13 hours ago

HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 5.96%

HK Disclosure
·
Oct 06

BlackRock's Long Position in H-Shares of Jiangsu Hengrui Increases to 6.99% on Sept 30 from 5.96% - HKEX

THOMSON REUTERS
·
Oct 05

UBS Group Ag's Long Position in H-Shares of Jiangsu Hengrui Pharmaceuticals Decreases to 4.59% on Sept 25 from 5.17% - HKEX

THOMSON REUTERS
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 5.96%

HK Disclosure
·
Oct 02

HENGRUI PHARMA: UBS Group AG Disposes of Shares, Long Position Falls to 4.59%

HK Disclosure
·
Oct 02

Movement Alert|HENGRUI PHARMA Falls 3.27% in Regular Trading, Profit-Taking After Novo Nordisk Deal Rally Amid Broad Pharma Sector Weakness

Market Focus
·
Oct 02

Hong Kong Stocks Close Higher as Property Stimulus Fails to Enthuse; Pharma Emerges as Safe Haven

Stock News
·
Sep 30

Daiwa: Hengrui Pharma (01276) Reaches Licensing Deal with Novo Nordisk for HRS-1596; Total Transaction Value and Upfront Payment Both Attractive

Stock News
·
Sep 30

Morgan Stanley Maintains Overweight Rating on Hengrui Pharma (01276) with HK$82 Target Price

Stock News
·
Sep 30

AI Drug Discovery Sector Heats Up: ChinaAMC Hang Seng Biotech (03069) Rises Over 4% Intraday, ChinaAMC Innovative Drugs (03525) Gains Over 3% in Afternoon Session

Stock News
·
Sep 30

HK Movers | Pharma Stocks Jump With CanSino Biologics up 19%, Joinn Laboratories up 17%

Tiger Newspress
·
Sep 30

Movement Alert|HENGRUI PHARMA Rises 3.33% in Regular Trading, Novo Nordisk Licensing Deal Worth Up to $2.6 Billion Continues to Fuel Rally

Market Focus
·
Sep 30

Hong Kong Stock Connect Innovative Drug Sector Defies Market Downturn as Top Pharmaceutical Firm Enters with US$2 Billion, Akeso Surges 15.54%, Hengrui Pharma Secures US$2.6 Billion BD Deal

Deep News
·
Sep 29

Novo Nordisk Strikes Second Licensing Deal Since Frosty Capital-Markets Day

Dow Jones
·
Sep 29

HENGRUI PHARMA: BlackRock, Inc. Disposes of Shares, Long Position Falls to 6.96%

HK Disclosure
·
Sep 29